These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6761023)

  • 1. Lack of association of human renal allograft rejection and circulating K-cell, NK-cell, or total T-cell levels.
    Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lee HM; Mohanakumar T
    Clin Immunol Immunopathol; 1982 Dec; 25(3):335-47. PubMed ID: 6761023
    [No Abstract]   [Full Text] [Related]  

  • 2. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitive monitoring of polyclonal antilymphocyte agents in renal transplantation.
    Clark KR; Taylor RM; Forsythe JL
    Clin Transpl; 1993; ():267-74. PubMed ID: 7918160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
    Hadaya K; Avila Y; Valloton L; de Rham C; Bandelier C; Ferrari-Lacraz S; Pascual M; Pantaleo G; Martin PY; Buhler L; Villard J
    Clin Immunol; 2010 Nov; 137(2):250-60. PubMed ID: 20719569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell count and antilymphocyte globulin therapy.
    Ippoliti G; Martinelli L; Negri M; Abelli P; Viganò M
    Transpl Int; 1994; 7(2):146. PubMed ID: 8179805
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of immunosuppressive drugs on human T, B, and K lymphocytes.
    Thomas F; Thomas J; Mendez G; Lower R; Lee HM
    Transplantation; 1977 Dec; 24(6):435-41. PubMed ID: 339440
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of interferon alpha on natural killer cell cytotoxicity in kidney transplant recipients.
    Kelly AP; Schooley RT; Rubin RH; Hirsch MS
    Clin Immunol Immunopathol; 1984 Jul; 32(1):20-8. PubMed ID: 6329567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.
    Rondelli D; Abbasian J; Arpinati M; Panaro F; Porubsky M; Manzelli A; Oberholzer J; Benedetti E; Testa G
    Transplant Proc; 2005; 37(1):49-50. PubMed ID: 15808543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 11. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating NK cell subsets and NKT‑like cells in renal transplant recipients with acute T‑cell‑mediated renal allograft rejection.
    Xu X; Han Y; Huang H; Bi L; Kong X; Ma X; Shi B; Xiao L
    Mol Med Rep; 2019 May; 19(5):4238-4248. PubMed ID: 30942398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 15. FLow cytometry quantitation of peripheral blood T-cell subsets as a monitor of renal allograft rejection.
    Binkley WF; Valenzuela R; Braun WE; Doedhar SD; Novick AC; Steinmuller DR; Williams G
    Cleve Clin Q; 1986; 53(3):249-56. PubMed ID: 3545549
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerance and suppressor T cells.
    Brent L
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies for kidney allograft rejection.
    Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural killer cells in renal allograft rejection.
    Cooksey G; Robins RA; Blamey RW
    Br J Surg; 1984 Nov; 71(11):874-7. PubMed ID: 6388720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between two-color flow cytometry quantitation of activated T cells and acute allograft rejection.
    Hayes JM; Valenzuela R; Novick AC; Steinmuller DR; Williams G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1605-8. PubMed ID: 3493570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.